Queensland Life Sciences Industry Report 2012 (PDF, 3.5MB)

Queensland Life Sciences Industry Report 2012
16
2b. INDUSTRY-WIDE ESTIMATES OF KEY
MEASURES
“Total population estimates for the 301 QLS organisations were generated
through a statistical extrapolation of aggregated data from 139 survey
respondents.”
2.12 Methodology and Rationale
The relatively high response rate to the survey
allowed us to attempt a statistical extrapolation
of the data obtained. For key measures including
employment, income and expenditure we employed
statistical methods to estimate totals for the entire
state of Queensland, based on the survey responses
received and assuming that non-responders could
be appropriately profiled based on the sector they
are part of and their size. Respondent organisations
were classified into a number of stratums based
on their size with respect to the number of FTE
employees.
Total population estimates were derived by applying
bootstrapped estimates of the mean within each
stratum to the 162 organisations that were not
able to participate in the survey this year (the size
of each of these non-responding organisations
was estimated with reference to other primary and
secondary data). These estimates are presented
in Table 3.
These estimates should be taken at face value
given that the variability in the population of nonresponders
is not known. Whilst the reliability
of the estimates cannot be assured, as within
any statistical extrapolation, this exercise was
undertaken in an attempt to enhance the utility of
the raw survey data. The estimates for 2011 were
derived in the same manner and using similar
methodology to our estimates for the 2009 survey,
and thus we offer a comparison of the estimates
for those two periods.
The figures are based on a statistical extrapolation
of aggregated data (referred to as ‘actual’ data)
from 139 organisations. These numbers were not
derived through economic modelling and this is not
an economic analysis of the industry. The estimates
are highly variable and dependent on the statistical
methodology employed (please see Important
Notice for further details).
Profile of the Full Industry as Represented in the
Queensland Government Database
In 2011, the QLS Industry included 301
organisations. Of those, 133 were deemed to be
operating in the Biotechnology division of the
industry, and 168 in the TMD division.
There were 252 public and private companies and
49 research organisations.
At 30 June 2011, 7.8% of ASX-listed Life Sciences
companies (n = 102) 7 were located in Queensland
and their average market capitalisation was $60.2
million. The total market capitalisation for all
ASX-listed Australian Life Sciences firms (102)
at 30 June 2011 was $35.0 billion (or $9.1 billion
excluding CSL Ltd, Cochlear Ltd and ResMed Ltd;
99 companies – average market capitalisation
$91.7 million).
7 As listed in the PricewaterhouseCoopers Life Sciences Index.
8 National Health and Medical Research Council, Successful NHMRC Grant applications for 2004 – 2009, http://www.nhmrc.gov.au/
funding/funded/outcomes/projects.htm; accessed 29 May 2012.
9 Australian Research Council, ARC Funded Research Projects - Trends Data Set 2002 – 2009,http://www.arc.gov.au/general/
searchable_data.htm